Detalles de la búsqueda
1.
Lung function of primary cooks using LPG or biomass and the effect of particulate matter on airway epithelial barrier integrity.
Environ Res
; 189: 109888, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32979995
2.
A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 h, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma.
Am J Hematol
; 92(5): 460-466, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28213943
3.
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma.
Br J Haematol
; 161(3): 357-66, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23432640
4.
Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial.
Int J Hematol
; 115(2): 222-232, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34797531
5.
Continuous in-home PM2.5 concentrations of smokers with and without a history of respiratory exacerbations in Iowa, during and after an air purifier intervention.
J Expo Sci Environ Epidemiol
; 30(5): 778-784, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32461549
6.
Indoor Particulate Matter From Smoker Homes Induces Bacterial Growth, Biofilm Formation, and Impairs Airway Antimicrobial Activity. A Pilot Study.
Front Public Health
; 7: 418, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-32039129
7.
Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study.
Clin Lymphoma Myeloma Leuk
; 16(3): 129-38, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26795075
8.
Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.
J Clin Oncol
; 33(34): 4039-47, 2015 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26351344
9.
Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer.
Eur J Cancer
; 49(12): 2633-42, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23642329
Resultados
1 -
9
de 9
1
Próxima >
>>